Clinical trial
Combination Chemotherapy In Treating Patients With Advanced Cancer
NCT00003925 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003925 |
|---|---|
| Title | Combination Chemotherapy In Treating Patients With Advanced Cancer |
| Official title | Phase I Study of Gemcitabine (Gemzar) and UFT/Leucovorin |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride, leucovorin calcium, tegafur-uracil |
| Enrollment | 36 |
| Start date | May 1, 1998 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | May 2, 2003 |
| Last update posted | Apr 8, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: